首页> 外文期刊>Chronobiology international >An observational study on disturbed peripheral circadian rhythms in hemodialysis patients
【24h】

An observational study on disturbed peripheral circadian rhythms in hemodialysis patients

机译:血液透析患者外周昼夜节律紊乱的观察研究

获取原文
获取原文并翻译 | 示例
       

摘要

The quality of life of hemodialysis (HD) patients is hampered by reduced nocturnal sleep quality and excessive daytime sleepiness. In addition to the sleep/wake cycle, levels of circadian biomarkers (e.g. melatonin) are disturbed in end-stage renal disease (ESRD). This suggests impaired circadian clock performance in HD patients, but the underlying mechanism is unknown. In this observational study, diurnal rhythms of sleep, serum melatonin and cortisol concentrations and clock gene mRNA expression are compared between HD patients (n = 9) and healthy control subjects (n = 9). In addition, the presence of circulating factors that might affect circadian rhythmicity is tested in vitro with cell culture experiments. Reduced sleep quality (median sleep onset latency [interquartile range] of 23.9 [17.3] min for patients versus 5.0 [10] minutes for controls, p < 0.01; mean (+/- SD) sleep efficiency 70.2 +/- 8.1% versus 82.9 +/- 10.9%, p = 0.02 and mean awake minutes after sleep onset 104.8 +/- 27.9 versus 54.6 +/- 41.6 minutes, p = 0.01) and increased daytime sleepiness (mean Epworth Sleepiness Score of 10.0 +/- 4.8 versus 3.9 +/- 2.0, p < 0.01) were confirmed in HD patients. Reduced nocturnal melatonin concentrations (1 AM: 98.1 [122.9] pmol/L versus 12.5 [44.2] pmol/L, p = 0.019; 5 AM: 114.0 [131.6] pmol/L versus 11.8 [86.8] pmol/L, p = 0.031) and affected circadian control of cortisol rhythm and circadian expression of the clock gene REV-ERB alpha were found. HD patient serum had a higher capacity to synchronize cells in vitro, suggesting an accumulated level of clock resetting compounds in HD patients. These compounds were not cleared by hemodialysis treatment or related to frequently used medications. In conclusion, the abovementioned results strongly suggest a disturbance in circadian timekeeping in peripheral tissues of HD patients. Accumulation of clock resetting compounds possibly contributes to this. Future studies are needed for a better mechanistic understanding of the interaction between renal failure and perturbation of the circadian clock.
机译:夜间睡眠质量下降和白天过多的嗜睡阻碍了血液透析(HD)患者的生活质量。除了睡眠/唤醒周期外,在终末期肾脏疾病(ESRD)中昼夜节律生物标志物(例如褪黑激素)的水平也受到干扰。这表明HD患者的昼夜节律时钟性能受损,但其潜在机制尚不清楚。在这项观察性研究中,比较了HD患者(n = 9)和健康对照组(n = 9)的睡眠昼夜节律,血清褪黑激素和皮质醇浓度以及时钟基因mRNA表达。另外,通过细胞培养实验在体外测试了可能影响昼夜节律性的循环因子的存在。睡眠质量下降(患者的中位睡眠开始潜伏期[四分位间距]为23.9 [17.3]分钟,对照组为5.0 [10]分钟,p <0.01;平均(+/- SD)睡眠效率为70.2 +/- 8.1%与82.9 +/- 10.9%,p = 0.02,平均睡眠开始后的清醒分钟数为104.8 +/- 27.9,而平均睡眠时间为54.6 +/- 41.6分钟,p = 0.01),白天嗜睡程度增加(平均爱普沃思嗜睡分数为10.0 +/- 4.8对3.9) +/- 2.0,p <0.01)在HD患者中得到确认。夜间褪黑激素浓度降低(1 AM:98.1 [122.9] pmol / L与12.5 [44.2] pmol / L,p = 0.019; 5 AM:114.0 [131.6] pmol / L与11.8 [86.8] pmol / L,p = 0.031 ),发现皮质醇节律的昼夜节律控制和时钟基因REV-ERB alpha的昼夜节律表达。 HD患者血清具有更高的体外细胞同步能力,表明HD患者中时钟重置化合物的累积水平。这些化合物未通过血液透析治疗清除或与常用药物有关。总之,上述结果有力地暗示了HD患者外周组织的昼夜节律计时受到干扰。时钟重置化合物的积累可能对此有所帮助。需要进一步的研究以更好地机械理解肾功能衰竭和昼夜节律时钟之间的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号